|
MaxzideDrug - Maxzide The trade name of the product as shown on the labeling.
Dosage -
TABLET; ORAL
Active Ingredient(s) -
Hydrochlorothiazide; Triamterene
Strength -
50MG;75MG
Applicant -
MYLAN BERTEK
New Drug Application (NDA) Number -
019129
Product Number -
001
Therapeutic Equivalence (TE) Code -
AB
Approval Date -
Oct 22, 1984
Reference Listed Drug (RLD) -
Yes
Type -
RX
Applicant Full Name -
Mylan Bertek Pharmaceuticals Inc
Maxzide
Triamterene And Hydrochlorothiazide 25mg;37.5mg Capsule; Oral
Triamterene And Hydrochlorothiazide 25mg;37.5mg Capsule; Oral Triamterene And Hydrochlorothiazide 25mg;37.5mg Capsule; Oral Triamterene And Hydrochlorothiazide 25mg;50mg Capsule; Oral Triamterene And Hydrochlorothiazide 25mg;50mg Capsule; Oral Maxzide 50mg;75mg Tablet; Oral Dyazide 25mg;50mg Capsule; Oral Triamterene And Hydrochlorothiazide 25mg;37.5mg Capsule; Oral Triamterene And Hydrochlorothiazide 25mg;37.5mg Capsule; Oral Triamterene And Hydrochlorothiazide 25mg;50mg Capsule; Oral NewDrugInformation |